Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 603

1.

Practical Management of Anticoagulation in Patients With Atrial Fibrillation.

Kovacs RJ, Flaker GC, Saxonhouse SJ, Doherty JU, Birtcher KK, Cuker A, Davidson BL, Giugliano RP, Granger CB, Jaffer AK, Mehta BH, Nutescu E, Williams KA.

J Am Coll Cardiol. 2015 Apr 7;65(13):1340-1360. doi: 10.1016/j.jacc.2015.01.049. Review.

PMID:
25835447
2.

Outcomes After Nonemergent Electrical Cardioversion for Atrial Arrhythmias.

Steinberg BA, Schulte PJ, Hofmann P, Ersbøll M, Alexander JH, Broderick-Forsgren K, Anstrom KJ, Granger CB, Piccini JP, Velazquez EJ, Shah BR.

Am J Cardiol. 2015 Feb 18. pii: S0002-9149(15)00726-2. doi: 10.1016/j.amjcard.2015.02.030. [Epub ahead of print]

PMID:
25784514
3.

Registry-based randomized clinical trials-a new clinical trial paradigm.

James S, Rao SV, Granger CB.

Nat Rev Cardiol. 2015 May;12(5):312-316. doi: 10.1038/nrcardio.2015.33. Epub 2015 Mar 17. Review.

PMID:
25781411
4.

Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs.

Verheugt FW, Granger CB.

Lancet. 2015 Mar 11. pii: S0140-6736(15)60245-8. doi: 10.1016/S0140-6736(15)60245-8. [Epub ahead of print] Review.

PMID:
25777666
5.

Patient load effects on response time to critical arrhythmias in cardiac telemetry: a randomized trial.

Segall N, Hobbs G, Granger CB, Anderson AE, Bonifacio AS, Taekman JM, Wright MC.

Crit Care Med. 2015 May;43(5):1036-42. doi: 10.1097/CCM.0000000000000923.

PMID:
25746509
6.

Strategic transformation of population studies: recommendations of the working group on epidemiology and population sciences from the national heart, lung, and blood advisory council and board of external experts.

Roger VL, Boerwinkle E, Crapo JD, Douglas PS, Epstein JA, Granger CB, Greenland P, Kohane I, Psaty BM.

Am J Epidemiol. 2015 Mar 15;181(6):363-8. doi: 10.1093/aje/kwv011. Epub 2015 Mar 4.

PMID:
25743324
7.

Roger et Al. Respond to "future of population studies".

Roger VL, Boerwinkle E, Crapo JD, Douglas PS, Epstein JA, Granger CB, Greenland P, Kohane I, Psaty BM.

Am J Epidemiol. 2015 Mar 15;181(6):372-3. doi: 10.1093/aje/kwv009. Epub 2015 Mar 4. No abstract available.

PMID:
25743323
8.

Long-term mortality of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation for acute and stable coronary artery disease.

Rohla M, Vennekate CK, Tentzeris I, Freynhofer MK, Farhan S, Egger F, Weiss TW, Wojta J, Granger CB, Huber K.

Int J Cardiol. 2015 Feb 10;184C:108-114. doi: 10.1016/j.ijcard.2015.02.004. [Epub ahead of print]

PMID:
25700281
9.

Should patients on vitamin K antagonists be treated differently?

Pokorney SD, Granger CB.

Eur Heart J. 2015 Feb 18. pii: ehv032. [Epub ahead of print] No abstract available.

PMID:
25694462
10.

Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme.

Badar AA, Perez-Moreno AC, Hawkins NM, Brunton AP, Jhund PS, Wong CM, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Gardner RS, Petrie MC, McMurray JJ.

Eur J Heart Fail. 2015 Feb;17(2):196-204. doi: 10.1002/ejhf.221.

PMID:
25678097
11.

Improving diabetes medication adherence: successful, scalable interventions.

Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB, Granger CB, Trygstad T, Liu LZ, Bosworth HB.

Patient Prefer Adherence. 2015 Jan 23;9:139-49. doi: 10.2147/PPA.S69651. eCollection 2015. Review.

12.

Potential relief for refractory angina.

Granger CB, Gersh BJ.

N Engl J Med. 2015 Feb 5;372(6):566-7. doi: 10.1056/NEJMe1413941. No abstract available.

PMID:
25651252
13.

Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-Up.

Alnasser SM, Huang W, Gore JM, Steg PG, Eagle KA, Anderson FA Jr, Fox KA, Gurfinkel E, Brieger D, Klein W, van de Werf F, Avezum Á, Montalescot G, Gulba DC, Budaj A, Lopez-Sendon J, Granger CB, Kennelly BM, Goldberg RJ, Fleming E, Goodman SG; on behalf of the GRACE Investigators.

Am J Med. 2014 Dec 29. pii: S0002-9343(14)01225-X. doi: 10.1016/j.amjmed.2014.12.007. [Epub ahead of print]

PMID:
25554379
14.

Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.

Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FW, Zhu J, Granger CB, Wallentin L.

Eur Heart J. 2014 Dec 12. pii: ehu463. [Epub ahead of print]

PMID:
25499871
15.

Clinical events after transitioning from apixaban versus warfarin to warfarin at the end of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.

Granger CB, Lopes RD, Hanna M, Ansell J, Hylek EM, Alexander JH, Thomas L, Wang J, Bahit MC, Verheugt F, Lawrence J, Xavier D, Wallentin L.

Am Heart J. 2015 Jan;169(1):25-30. doi: 10.1016/j.ahj.2014.09.006. Epub 2014 Sep 28.

PMID:
25497244
16.

Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: a report from the US National Cardiovascular Data Registry.

Vora AN, Holmes DN, Rokos I, Roe MT, Granger CB, French WJ, Antman E, Henry TD, Thomas L, Bates ER, Wang TY.

JAMA Intern Med. 2015 Feb;175(2):207-15. doi: 10.1001/jamainternmed.2014.6573.

PMID:
25485876
17.

Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy.

Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L.

Clin Chem. 2015 Feb;61(2):368-78. doi: 10.1373/clinchem.2014.226936. Epub 2014 Dec 1.

PMID:
25451868
18.

How can we optimize the processes of care for acute coronary syndromes to improve outcomes?

Wallentin L, Kristensen SD, Anderson JL, Tubaro M, Sendon JL, Granger CB, Bode C, Huber K, Bates ER, Valgimigli M, Steg PG, Ohman EM.

Am Heart J. 2014 Nov;168(5):622-31. doi: 10.1016/j.ahj.2014.07.006. Epub 2014 Jul 21. Review.

PMID:
25440789
19.

Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?

Huber K, Bates ER, Valgimigli M, Wallentin L, Kristensen SD, Anderson JL, Lopez Sendon JL, Tubaro M, Granger CB, Bode C, Ohman EM, Steg PG.

Am Heart J. 2014 Nov;168(5):611-21. doi: 10.1016/j.ahj.2014.06.014. Epub 2014 Jun 26. Review.

PMID:
25440788
20.

Simultaneous consideration of multiple candidate protein biomarkers for long-term risk for cardiovascular events.

Halim SA, Neely ML, Pieper KS, Shah SH, Kraus WE, Hauser ER, Califf RM, Granger CB, Newby LK.

Circ Cardiovasc Genet. 2015 Feb;8(1):168-77. doi: 10.1161/CIRCGENETICS.113.000490. Epub 2014 Nov 24.

PMID:
25422398
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk